Tudóstér: Nagy Lőrinc publikációi

Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15 1-38, 2024.

Sipos, F., Bohusné Barta, B., Simon, Á., Nagy, L., Dankó, T., Raffay, R., Petővári, G., Zsiros, V., Wichmann, B., Sebestyén, A., Műzes, G.: Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response.
Pathol. Oncol. Res. 28 1-15, 2022.

Bohusné Barta, B., Simon, Á., Nagy, L., Dankó, T., Raffay, R., Petővári, G., Zsiros, V., Sebestyén, A., Sipos, F., Műzes, G.: Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.
PLoS One. 17 (5), 1-25, 2022.

Műzes, G., Sebestyén, A., Simon, Á., Nagy, L., Barta, B., Danko, T., Kiss, A., Sipos, F.: IGF1R inhibition affects the survival of HT29 cancer cells by alterations of the TLR9- and autophagy signaling.
Ann. Oncol. 30 (Suppl_5), 806-807, 2019.

Sipos, F., Nagy, L., Barta, B., Simon, Á., Danko, T., Sebestyén, A., Kiss, A., Műzes, G.: Modulation of TLR9-dependent autophagy response via inhibition of c-Met signaling influences the survival of HT29 cancer cells.
Ann. Oncol. 30 (Suppl_5), v807, 2019.